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Abstract
Defects in DNA replication are implicated as early and causal events in malignancy. However, the
immediate effects of impaired DNA replication licensing on cell cycle progression of non-
malignant human cells are unknown. Therefore, we have investigated the acute effects of Mcm7
ablation using synchronized cultures of untransformed Human Dermal Fibroblasts (HDF). Mcm7
ablation elicited a G1 delay associated with impaired activation of CDK4 and CDK2 and reduced
Rb phosphorylation. The cell cycle delay of Mcm7-ablated cells was not associated with a DNA
damage response. However, levels of cyclin D1 mRNA were specifically reduced and binding of
RNA Polymerase II to the CYCD1 promoter was decreased in Mcm7-depleted cells. Similar to
Mcm7-deficiency, Mcm2- or Cdc6-depletion led to impaired cyclin D expression. Ectopic
overexpression of Cdc6 in quiescent cells promoted cyclin D1 expression, CDK4 activation and
G1 progression. Therefore timely and efficient expression of cyclin D1 during G1 phase requires
replication licensing. Reconstitution of cyclin D1 expression was insufficient to correct the G1
delay of Mcm7-depleted cells, indicating that additional cell cycle events during G1 are dependent
on replication licensing. However, ectopic expression of the HPV-E7 oncoprotein, and the
resulting bypass of the requirement for cyclin D1-Rb signaling enabled Mcm7-depleted cells to
enter S-phase. HPV-E7-induced S-phase entry of Mcm7-depleted cells led to a DNA damage
response, a hallmark of pre-malignancy. Taken together, our results suggest the existence of a
‘replication licensing restriction point’ that couples pre-RC assembly with G1 progression in
normal cells to minimize replication stress, DNA damage and tumorigenesis.
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Introduction
Accurate replication and repair of DNA is crucial for maintaining genomic stability. To
ensure faithful genome duplication, eukaryotic DNA replication is a highly ordered process
involving regulated assembly and disassembly of protein complexes at origins of DNA
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replication. The Origin Recognition Complex (ORC), comprising ORC subunits 1–6 binds
to origins of replication throughout the cell cycle. During late M-phase and G1 the mini-
chromosome maintenance (Mcm) complex (Mcm2-7) is recruited to origins by the
molecular chaperones Cdt1 and Cdc6, to form pre-replicative complexes or pre-RC (a
process termed ‘replication licensing’).1-3 At the onset of S-phase, Cyclin-Dependent
Kinases (CDKs) and Cdc7 convert pre-RC into Initiation Complexes (ICs). IC formation
involves recruitment of initiation factors such as Mcm10 and Cdc45, melting of origin DNA,
association of ssDNA-binding proteins, and loading of the Pol α-primase complex to
synthesize the RNA primer necessary for subsequent DNA replication.1
Appropriate control of DNA replication and its integration with other cell cycle events is
critical for maintaining genome stability and preventing transformation. Precisely how
replication licensing is coordinated with other cell cycle events during G1 is not fully
understood. A key event required for normal G1 to S-phase transition is phosphorylation-
mediated inactivation of the retinoblastoma (Rb) tumor suppressor protein. Rb is a
transcriptional repressor that negatively regulates G1 progression by inhibiting the E2F
transcription factors. E2F family members regulate expression of genes important for S-
phase entry and progression (including CYCA2, DHFR and CDC45).4 Thus, active Rb
negatively regulates cell cycle progression through G1 (at least in large part) by repressing
E2F. Inhibition of Rb by mitogenic stimuli or oncogenes de-represses E2F activity thereby
inducing E2F-responsive genes and promoting cell cycle progression.5,6
Rb inactivation is mediated by the concerted action of G1-phase CDKs.7,8 CDKs
phosphorylate multiple sites on Rb, resulting in its displacement from chromatin and de-
repression of E2F. The CDKs responsible for phosphorylation and inactivation of Rb are
CDKs 4 and 6 (which are cyclin D-dependent) and CDK2 (which is cyclin E-dependent).
During mid-G1, CDK4/6-dependent phosphorylation of Rb at multiple sites results in E2F-
mediated transcriptional induction of the Cyclin E gene, CYCE.9,10 Expression of Cyclin E
and the ensuing activation of CDK2 induces hyper-phosphorylation of Rb and further de-
repression of E2F activity. The G1-S transition is triggered when E2F activity reaches a
critical threshold level. Regulation of CDKs occurs via multiple mechanisms, including
assembly of CDK complexes, inhibitory and activating phosphorylation events, and
association with cyclin-dependent kinase inhibitors (CKIs). Moreover, CDK inhibitors of
the Cip/Kip and Ink4 families play key roles in regulating CDK activity and controlling the
G1-Sphase transition. In addition to promoting expression of E2F-induced genes, CDK
activities play important roles in regulating the licensing and initiation stages of DNA
synthesis. For instance, the stabilization and accumulation of Cdc6 in G1 is CDK2-
dependent,11 and recruitment of initiation factors and the onset of DNA synthesis is
triggered by cyclin E-CDK2 and cyclin A-CDK2,2 (and also Cdc7).
Thus it is clear that G1 progression and S-phase entry require CDK activities. Most likely, it
is important for cells to enter S phase only after sufficient numbers of origins have been
licensed. S-phase entry of cells containing too few licensed origins could necessitate more
DNA synthesis per licensed origin, potentially leading to replication stress, incomplete DNA
synthesis, or other causes of genomic instability. Indeed, transgenic mice harboring a
hypomorphic Mcm4 allele are cancer-prone,12 suggesting that defective replication licensing
promotes genomic instability and leads to cancer.
The effects of impaired Mcm2-7 helicase expression or activity on cell cycle regulation of
untransformed human cells have not been characterized. However, Blow and colleagues
have shown that inhibiting licensing using degradation-resistant geminin results in reduced
Cyclin E-CDK2 activity and G1 arrest.13 Similarly, Dutta and colleagues have shown that a
‘replication licensing checkpoint’ due to ORC-deficiency elicits p21/p27 induction and
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inhibits G1/S progression.14 It is unknown whether p27 induction and the resulting
inhibition of Cyclin E-CDK2 represent the only mechanisms for inhibiting G1 progression in
response to impaired replication licensing. Moreover, the previous studies of replication
licensing checkpoints were performed using asynchronous cells,13,14 potentially
complicating analysis and interpretation of events in G1. Therefore, we have investigated the
relationship between Mcm7, replication licensing and mitogenic signaling events during G1
using synchronized cultures of untransformed human cells. We demonstrate that
untransformed cells respond to impaired replication licensing by inhibiting cyclin D1
expression very early during G1. The effect of impaired replication licensing on cyclin D1 is
dissociable from the p27/cyclin E-CDK2-mediated mechanisms described previously.13,14
We conclude that regulation of cyclin D1 expression represents a novel mechanism for
cordinating replication licensing with G1 progression.
Results
Downregulation of Mcm7 inhibits S-phase entry of synchronized HDFs
To determine the effects of reduced replication licensing on cell cycle progression, we used
siRNA to deplete Mcm7 in quiescent Human Dermal Fibroblasts (HDF). Mcm7-depleted
cells (or cells transfected with control siCon RNA duplexes) were stimulated to re-enter the
cell cycle for 24 hr. As shown in Figure 1A, a significant reduction of Mcm7 expression was
achieved in both soluble and chromatin fractions after siRNA treatment. Depletion of Mcm7
also resulted in reduced levels of Mcm2 on chromatin (Fig. 1A), indicating that Mcm7
knockdown interfered with assembly of the Mcm2-7 complex and prevented pre-RC
formation. We next asked whether the levels of Mcm7 depletion attained under our
experimental conditions affected cell cycle progression or DNA replication. Therefore,
numbers of cells actively synthesizing DNA were determined using BrdU incorporation and
flow cytometry. As shown in Figure 1B, Mcm7-depleted cells failed to enter S-phase as
evidenced by the absence of BrdU-positive populations. Therefore, Mcm7-depletion
prevented cell cycle progression of synchronized HDF.
We determined the effect of Mcm7-deficiency on the integrity of known mitogenic signaling
events during G1-S progression. Our immunoblotting experiments showed that expression of
cyclins E and A (which are encoded by E2F-inducible genes) were reduced in Mcm7-
depleted cells relative to controls (Fig. 1A). Rb phosphorylation at S780 (a CDK4-specific
site) was undetectable in Mcm7-depleted cells (Fig. 1A). Our failure to detect S780
phosphorylation also resulted in part from the reduced expression of total Rb in Mcm7-
depleted cells. Similar to cyclins E and A, the RB gene is transcriptionally regulated by E2F.
5 Therefore, the reduced levels of cyclin E, cyclin A and Rb in Mcm7-depleted HDF may be
consistent with reduced de-repression of E2F as a result of Mcm7-deficiency.
The initial phosphorylation of Rb and de-repression of E2F during mid-G1 are due to cyclin
D1-CDK4 activity. Therefore, we determined the effect of Mcm7 depletion on CDK4
activity in serum-stimulated HDF. CDK4 was immunoprecipitated from control and Mcm7-
depleted HDF at different times after serum treatment. The CDK4 activity of the resulting
immune complexes was measured in vitro using GST-Rb as a substrate. As expected, CDK4
activity was detectable at 12 hr following serum stimulation (a time point corresponding to
mid-G1) in control HDF (Fig. 1C). Interestingly, CDK4 activity was reduced by >80% in
Mcm7-depleted cells relative to controls (Fig. 1C).
Since CDK4-dependent Rb inactivation contributes to subsequent CDK2 activation in late
G1 (due to induction of cyclins E and A), we also determined the effect of Mcm7-depletion
on CDK2 activity. As shown in Figure 1C, CDK2 activity was first detectable in control
HDF after 15 hours of serum stimulation, a time point subsequent to onset of CDK4 activity.
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However, similar to CDK4 activity, CDK2 activation was reduced in Mcm7-depleted cells
(Fig. 1C). Therefore, appropriate levels of Mcm7 are necessary for activation of CDK4 and
CDK2 during G1. While it is reported that replication licensing is required for CDK2
activation,13,14 a role for pre-RC assembly in CDK4 activation has not previously been
described. Therefore we performed further experiments to investigate the novel link between
replication licensing and CDK4.
Mcm7-depletion prevents cyclin D1 expression during early G1
Full activation of CDK4 during G1 requires cyclin D1. To test whether altered cyclin D1
expression contributes to the reduced CDK4 activity of Mcm7-depleted cells we determined
the effects of Mcm7-depletion on cyclin D1 levels. As shown in Figure 2A, levels of cyclin
D1 protein in Mcm7-depleted cells were reduced relative to control (siCon) cultures. The
differences in cyclin D1 expression between control and Mcm7-depleted cells were most
evident at times corresponding to early G1 (0–4 h time point after serum treatment).
Interestingly, levels of CDK4 and Rb protein were also reduced in response to Mcm7-
depletion (Fig. 2A).
We investigated the mechanism(s) by which Mcm7-depletion led to reduced expression of
cyclin D1. Levels of cyclin D1 in Mcm7-depleted cells were not increased in response to
proteasome inhibition (data not shown), suggesting that reduced D1 levels were not due to
increased protein turnover. However, cyclin D1 mRNA levels were decreased as a result of
Mcm7-depletion (Fig. 2B). Moreover, using ChIP assays we failed to detect serum-induced
association of RNA PolII with the CYCD1 promoter in Mcm7-depleted cells (Fig. 2C).
Reduced cyclin D1 transcription was not accompanied by a defect in growth factor signaling
to ERK activation (Fig. 2A). Taken together, our results suggest that efficient transcriptional
induction of cyclin D1 during G1 is dependent on Mcm7 at a step subsequent to ERK
activation which involves recruitment of RNA PolII to the CYCD1 promoter.
To determine whether the effect of Mcm7 siRNA on the serum inducibility of Cyclin D
might be due to a general perturbation of the serum response in Mcm7-depleted fibroblasts,
we performed genome-wide gene-expression profiling of the serum response of Mcm7-
depleted and control-siRNA-treated cells using Affymetrix Gene Arrays. We specifically
focused our analysis on the expression of genes whose expression is induced by serum in
primary human fibroblasts isolated from diverse anatomic sites
(www.ncbi.nlm.nih.gov/sites/entrez?
CrntRpt=DocSum&cmd=search&db=pubmed&term=14737219). We retrieved the gene
symbols corresponding to 205 of these genes from the MSigDB database
(www.pnas.org/content/102/43/15545.abstract), of which we were able to match 195 with
probesets on the Affymetrix Gene Array. In cells treated with control siRNA, 75.4% of these
195 genes showed higher expression following addition of serum to serum-starved cells
(binomial test p-value << 0.001). Similarly, in cells treated with Mcm7-targeting siRNA,
79.5% of these genes were induced following addition of serum (binomial test p-value <<
0.001). Induction of the CYCD1 promoter is largely SRF-mediated, yet our microarray
analyses indicated that Mcm7-depletion did not inhibit the serum-inducible expression of
SRF-containing genes. Taken together, these results suggest that Mcm7-depleted fibroblasts
have a generally intact gene-expression response to serum. We conclude that the effect of
Mcm7-deficiency on cyclin D1 expression is relatively specific.
Mcm7-deficiency affects expression of cyclin D1 and p27 via independent mechanisms
Reportedly, impaired replication licensing during G1 inhibits CDK2 via a p27-dependent
mechanism.13,14 Consistent with those studies, p27 expression was induced in Mcm7-
depleted HDF concomitant with reduction of cyclin D1 (Fig. 2A). To determine whether the
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effect of Mcm7-deficiency on Cyclin D1 expression was related to the induction of p27, we
performed co-silencing experiments in which we ablated expression of Mcm7 and p27
individually or in combination. As shown in Figure 2D, silencing of p27 did not restore
expression of cyclin D1 in Mcm7-depleted cells. Therefore, the decreased expression of
cyclin D1 in Mcm7-depleted HDF is not due p27 induction.
We asked whether the changes in expression of cyclin D1 and p27 in Mcm7-depleted HDF
could be reversed by mitogenic stimuli that promote G1 progression. Therefore, we
investigated the effect of constitutive Raf1/ERK signaling on levels of cyclin D1 and p27 in
Mcm7-depleted cells. As shown in Figure 2E, ectopic overexpression of Raf1 and ERK
prevented the induction of p27, but did not affect the repression of cyclin D1 in Mcm7-
depleted cells. Therefore, Mcm7-depletion induces p27 expression and reduces cyclin D1
levels via dissociable mechanisms. Taken together, our results demonstrate the existence of
at least two independent mechanisms (involving cyclin D1 repression and p27 induction) for
coupling restriction licensing with G1 progression in untransformed cells.
Mcm7-deficiency does not elicit a DNA damage-induced G1 checkpoint response
Mitogenic signaling events in G1 are often subject to negative regulation by checkpoint
signaling.15-19 We considered the possibility that the reduced activation of CDK4 in Mcm7-
ablated cells was the result of a checkpoint response to reduced replication licensing. To
address this possibility, we determined the activation status of known checkpoint pathways
following Mcm7 ablation. As shown in Figure 3, Mcm7-deficiency did not affect p53 or p21
levels, indicating that p53 was not activated in response to reduced replication licensing. We
observed no increase in levels of γH2AX, an ATM and ATR substrate which is
phosphorylated in response to bulky DNA lesions and stalled replication forks. Moreover,
we did not detect changes in the phosphorylation status of Chk1 and Chk2 (DNA damage-
activated checkpoint kinases and effectors of ATR and ATM respectively). As expected,
treatment with BPDE (a bulky adduct-forming genotoxin) elicited checkpoint kinase
activation and p53 accumulation, indicating that our failure to detect checkpoint signaling in
Mcm7-depleted HDF was not due to defective checkpoint activation in these cells. Taken
together, our analyses do not suggest that checkpoint signaling is induced (within the
sensitivity limits of our assays) in response to Mcm7 ablation during G1.
Cyclin D1 expression is sensitive to Cdc6 status
Similar to the effects of Mcm7-depletion, siRNA-mediated ablation of Mcm2 inhibited
cyclin D1 expression during early G1 (data not shown), consistent with a role for replication
licensing in promoting cyclin D1 induction. However, Mcm2-7 proteins are reported to
participate in processes unrelated to DNA replication.20,21 Potentially, the effects of Mcm2-
or Mcm7-deficiency on Cylin D1 (and other G1 signaling events) might result from a
replication licensing-independent role of Mcm proteins. To further test a hypothetical link
between replication licensing and G1 progression we investigated the effects of Cdc6 status
on cyclin D1 expression. First we tested the effects of Cdc6-depletion on Cyclin D1 levels.
Using siRNA we achieved good ablation of Cdc6 expression which also led to reduced
levels of Mcm7 on chromatin as expected (Fig. 4A).
Similar to the effects of Mcm7- and Mcm2-deficiency, Cdc6-depletion prevented S-phase
entry and led to reduced expression of cyclin D1 protein during early G1 (Fig. 4A). Since
depletion of either Mcm7, Mcm2 or of Cdc6 impaired cyclin D1 expression, it is most likely
that cyclin D1 expression requires prior replication licensing, and that cyclin D1 expression
is not specifically dependent on Mcm7.
Liu et al. Page 5













Next we asked whether induction of replication licensing in quiescent cells would stimulate
mitogenic events during G1. Ectopic expression of Cdc6 in quiescent fibroblasts is sufficient
to induce replication licensing.22 Therefore, we used an adenovirus vector to express Cdc6
(or ‘empty’ vector for control) in quiescent HDF. A mutant Cdc6 harboring four Ser > Ala
substitutions at CDK phosphorylation sites (‘Ad HA-Cdc6-A4’) was used to promote
nuclear retention of the overexpressed licensing factor.23 As expected, ectopic expression of
HA-Cdc6-A4 in quiescent HDF accelerated rates of G1/S progression (shown by the FACS
profiles and DNA synthesis assays in Fig. 4B and C respectively). Interestingly, cyclin D1
expression was induced prematurely in quiescent cells as a result of Ad HA-Cdc6-A4
expression (Fig. 4C, compare lanes 1 and 2). Moreover, CDK4 activity (measured in vitro)
was elevated in HA-Cdc6-A4-expressing cells relative to controls (Fig. 4D). Taken together,
the results of our Cdc6 ablation and overexpression studies suggest that replication licensing
promotes cyclin D expression.
Perturbation of the Rb pathway confers S-phase entry of Mcm7-depleted cells
The results of Figures 2 and 4 indicated that efficient expression of cyclin D is promoted by
replication licensing. Therefore, we asked whether reconstitution of cyclin D1 expression
was sufficient to allow G1 progression and S-phase entry of Mcm7-depleted cells. We used
an adeno-virus vector to express cyclin D1 in control and Mcm7-depleted HDF. As shown
in Figure 5A, adenovirus-mediated gene delivery allowed us to achieve levels of cyclin D1
in Mcm7-depleted cells that were equivalent to those present in serum-stimulated control
HDF during G1. However, using FACS analyses and [3H]-thymidine incorporation synthesis
assays, we were unable to detect any effect of ectopically-expressed cyclin D1 on S-phase
entry of Mcm7-depleted cells (data not shown). Consistent with this result, overexpressed
cyclin D1 failed to correct the reduced expression of cyclin A (a necessary factor for DNA
replication) in Mcm7-depleted cells (Fig. 5A). The induction of p27 in Mcm7-ablated cells
was unaffected by Cyclin D1 overexpression, further suggesting that p27 induction and
Cyclin D1 repression are independent responses to impaired replication licensing.
Interestingly, the reduced expression of CDK4 and the reduced expression and
phosphorylation of Rb in Mcm7-depleted cells (also evident in Fig. 2A) were not corrected
by overexpressed cyclin D1 (Fig. 5A). We conclude that replication licensing is required not
only for efficient expression of cyclin D1, but also for other key mitogenic events involving
the CDK4-RB signaling axis during G1.
Activated oncogenes frequently enable cells to overcome restriction points that are
otherwise imposed on normal cell cycle progression. Therefore, we asked whether ectopic
expression of the HPV E7 oncoprotein (which inactivates Rb and other pocket proteins
involved in regulating transcriptional events during G1) would permit S-phase entry of cells
with impaired replication licensing. Quiescent cells were sequentially transfected with
siMcm7 (or siCon), infected with AdE7 (or an ‘empty’ control adenovirus vector, AdCon),
then stimulated with serum. We performed FACS analyses to quantify the early S-phase
(BrdU-positive) populations of the cells after serum treatment. In AdCon-infected cells,
Mcm7-depletion resulted in an 84% reduction of the early S-phase population (Fig. 5C,
upper). Interestingly however, in E7-expressing cells, S-phase entry was only inhibited by
19% as a result of Mcm7-depletion (Fig. 5B, lower). In E7-expressing and Mcm7-depleted
HDF, the BrdU-positive cells did not advance beyond early S-phase (data not shown),
presumably due to insufficient replicative helicase activity in Mcm7-depleted cells.
Nevertheless, our results clearly demonstrate that the E7 oncoprotein confers G1 progression
and S-phase entry of Mcm7-depleted cells.
As expected, cyclin A expression (a marker of early S-phase) was attenuated as a result of
Mcm7 depletion in AdCon-infected HDF (Fig. 5C). In contrast, in E7-expressing cells,
cyclin A levels were only modestly reduced as a result of Mcm7 depletion (Fig. 5C).
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We predicted that there would be detrimental consequences of S-phase entry in licensing
factor-depleted cells containing insufficient pre-RC. Therefore, we asked whether S-phase
entry in Mcm7-depleted cells was associated with markers of replication fork collapse and
DSB. As shown in Figure 5C, Mcm7 ablation led to induction of γH2AX in AdE7-infected
(but not AdCon-infected) cells concomitant with S-phase entry. Taken together, our results
suggest that in untransformed cells cyclin D1 expression and other key mitogenic events in
G1 require Mcm7 expression and replication licensing. Moreover, our HPV-E7 expression
results show that oncogene-induced bypass of the replication licensing restriction point
results in inappropriate S-phase entry leading to replication stress and DNA damage-
signaling.
Discussion
We show here that in untransformed human cells, the appropriate and timely expression of
cyclin D1 and the subsequent execution of subsequent signaling events during G1 is
promoted (at least in part) by replication licensing (Fig. 6). Potentially, direct associations
between pre-RC components and the transcriptional apparatus could contribute to induction
of important cell cycle genes including CYCD1. It has previously been suggested that
licensing factors cooperate with transcriptional activators to regulate gene expression. For
example, Mcm5 interacts directly with the transcriptional activator domain of Stat1α.24
Moreover, Mcm5 is recruited to Stat1 target genes25 and is essential for IFNγ-induced gene
expression.26 Since the cyclin D1 promoter is responsive to the Jak/Stat pathway, regulation
of Stat family members by Mcm7 could explain the effects of Mcm7 and Cdc6 status on
cyclin D1 expression which we have observed.
Reduced cyclin D1 expression alone is insufficient to account fully for the G1 delay
experienced by Mcm7-depleted cells. As shown in Figure 1C, at time points when cyclin D1
expression finally resumes in Mcm7-depleted cells, CDK4 activity and subsequent CDK2
activity remained attenuated. Moreover, Cyclin D1 reconstitution was insufficient to confer
S-phase entry (Fig. 5A). These data indicate the existence of additional Mcm7-dependent
mitogenic events during G1. Therefore, it is likely that licensed origins facilitate additional
cell cycle events via transcriptional (or nontranscriptional) mechanisms. The CDK4 gene
may also be negatively regulated in Mcm7-deficient cells, as shown by the inhibitory effect
of Mcm7-depletion on CDK4 mRNA and protein levels. Potentially, direct interactions
between pre-RC components and transcriptional machinery might be involved in regulating
the expression of CYCD1, CDK4, and perhaps other cell cycle genes. Consistent with this
possibility, higher order complexes of mammalian RNA Pol II have been found to contain
Mcm proteins and specific interactions of the Mcm2-7 complex with RNA Pol II
holoenzyme are mediated at least in part via Mcm2.27 Moreover, antibodies against Mcm2
inhibit transcription in Xenopus oocytes.28
The use of dual-function proteins which participate in DNA replication and transcription is
not unique to vertebrate cells.29 For example, Mcm7 modulates expression of several cell
cycle genes (MCM7, MCM5, CDC6) in S. cerevisiae by facilitating association of the
transcriptional regulator Mcm1 with specific promoter elements.21 Interestingly, the histone
chaperone FACT (facilitates active transcription), has been identified in Mcm2-7 helicase
complexes in yeast30 and in mammalian cells.31 FACT allows transcriptional elongation by
RNA Pol II and might also promote formation of transcriptional initiation complexes by
stimulating recruitment of TBP to TATA boxes.32 Because FACT is present in Mcm2-7
complexes during G1,30,31 it is conceivable that licensed origins stimulate gene transcription
via recruitment of FACT to promoters.
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Communication between licensed origins and the transcriptional machinery may even occur
in a bi-directional manner. For example, RNA Pol II is recruited to ARS and artificially
tethering Pol II CTD to origins of replication stimulates minichromosome stability.33
Therefore, replication licensing is clearly coupled to transcriptional events in many
instances. Many components of the G1 cell cycle machinery are reported to interact directly
with the pre-RC, including cyclin-CDK complexes and Rb.11,34-39 Thus the pre-RC may
serve as a central ‘hub’ for bi-directional communication between the DNA replication
apparatus, the transcriptional machinery and cyclin-CDKs, thereby coordinating DNA
synthesis with other cell cycle events.
Coordinating G1 cyclin expression and CDK activation with pre-RC assembly provides a
potential mechanism for ensuring that replication competency is attained prior to initiation
of DNA synthesis. G1 CDK activity is sufficient to induce DNA synthesis in quiescent
human fibroblasts.40 Uncoupling of CDK activity from pre-RC formation (a likely event in
tumor cells with defective Rb signaling) could result in S-phase entry with insufficient
licensed origins. Completion of DNA replication in cells containing suboptimal levels of
Mcm2-7 helicase complexes could impose a greater work load per replicon, thereby
increasing replication-associated errors and replication stress. For example, sub-optimal
recruitment of helicase complexes could slow DNA replication due to inefficient template
unwinding. The resulting persistence of replication forks could increase the risk of breakage
of fragile and unstable DNA replication intermediates or could result in more frequent
collisions with other chromatin-associated complexes (such as the transcriptional apparatus),
another potential cause of DNA damage. Indeed, our results show that Mcm7-ablation in
HPV-E7 oncogene-expressing cells elicits checkpoint signaling via Chk2 and a γH2AX,
both hallmarks of a DNA damage response.
The Mcm2-7 complex (together with GINS and Cdc45) constitutes the replicative helicase,
which is responsible for establishing checkpoints during S phase. Therefore, S phase in cells
with reduced levels of helicase activity would likely lead to impaired checkpoint activation
in response to intrinsic/extrinsic sources of DNA damage. S phase checkpoints play key
roles in stabilizing replication structures, and regulating DNA repair (e.g., via HR and PRR).
Therefore, it is likely that defects resulting from reduced replication licensing might
contribute to chromosome instability and cancer. Blow and colleagues have suggested that
the cellular pool of Mcm2-7 exceeding that required for DNA synthesis during an
unperturbed cell cycle is necessary to allow re-licensing and re-priming events downstream
of stalled forks.41 Consistent with a role for excess Mcm in replication fork recovery, a
Mcm4 hypomorph mouse that exhibits a severe reduction in licensing shows significant
chromosomal abnormalities after treatment with aphidicolin.12
While other published studies have examined the consequence of depleting pre-RC
components in human cells.14,42 Our work is the first to suggest that Cyclin D-CDK4 is
linked to replication licensing. Dutta and colleagues showed that Orc2 depletion affects G1
progression in cancer cells via a mechanism involving p27 stabilization and cyclin E-CDK2
inhibition.14
Our results are fully consistent with those of the Dutta group, but additionally we
demonstrate that cyclin D expression (an early-mid G1 event) is inhibited in response to
Mcm7-depletion independently of changes in p27 expression, at least in untransformed cells
(Fig. 6). It is possible that the G1 licensing restriction point targeting cyclin D1 in primary
untransformed cells is absent in tumor cells. Indeed, defects in G1 checkpoints are frequently
observed in cancer cells. Moreover, our Mcm7-ablation studies were conducted in
synchronized HDF undergoing G0/G1 progression, whereas the effects of Orc2-deficiency
were examined using asynchronous populations. Cancer cells typically fail to enter G0 and
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have a relatively short G1-phase. Therefore, it is likely that negative regulation of G1 events
(such as cyclin D1 expression) is not as readily observed in cancer cell lines. Finally, it is
possible that Orc2-depletion and Mcm7-deficiency trigger distinct restriction points that
target CDK2 and CDK4 respectively. Taken together, it appears that multiple events
involved in efficient CDK activation and cell cycle progression through G1 require
appropriate replication licensing.
Most DNA replication factors were initially identified and characterized in yeast. The
processes of cell cycle and DNA replication are very similar in all eukaryotes, though there
much complexity has been acquired during metazoan evolution. Yeast possess functional
equivalents of cyclins and CDKs, and Rb. Interestingly however, the response to replication
licensing factor depletion observed in yeast differs from what we and others have observed
in cultured mammalian cells. In S. cereviseae, loss of Cdc6 or Mcm resulted in bypass of S-
phase and direct entry from G1 into M, followed by a form of reductional mitosis.43,44 Thus,
budding yeast lack a G1 licensing restriction point. Reduced Orc2 protein levels in the
ORC2-1 temperature-sensitive mutant result in reduced replication licensing. The
incompletely-licensed ORC2-1 mutants enter S-phase at the same rate as wild-type cells but
require more time to complete DNA synthesis.45-47 The incidence of irreversible cell cycle
arrest and apoptosis is also higher in ORC2 mutants suggesting that irreparable DNA
damage is acquired in cells with insufficient numbers of licensed origins.48-50 Therefore, the
G1 licensing restriction point we have identified in mammalian cells may have evolved in
multicellular organisms to coordinate growth and proliferation during various stages of
development, and to guard against tumorigenesis.
It will be important to determine whether the replication licensing restriction point targeting
cyclin D/CDK4 is commonly lost in cancer cells. Since the Rb signaling axis is defective in
many tumors, we anticipate that oncogene-expressing cells will enter S-phase
inappropriately when replication licensing is impaired (as we have shown for E7-expressing
HDF). Moreover, it is likely that replication-associated stress and DNA damage incurred
due to the inappropriate S-phase entry of pre-malignant cells with impaired replication
licensing contributes to tumorigenesis. Indeed, it has been suggested that reduced Mcm2
expression results in stem/progenitor cell deficiency and cancer.51 Clearly further studies are
necessary to elucidate the mechanisms that sense pre-RC formation and couple replication
licensing with G1 progression. Additionally, it will be interesting to determine whether other
partially redundant or failsafe restriction point mechanisms prevent CDK activation in
response to incomplete replication licensing.
Materials and Methods
Cells and culture
Human Dermal Fibroblasts (HDF) were cultured in Dulbecco's modified Eagle's medium
supplemented with 10% fetal bovine serum, streptomycin sulfate (100 μg/ml) and penicillin
(100 units/ml). Cells were routinely passaged every third day at ratios of 1:3–1:5. Primary
HDF were typically used prior to passage 10. In some experiments, HDF were retrovirally
transduced with the human telomerase (hTERT) cDNA to prolong their replica-tive lifespan.
Qualitatively similar results were obtained when using HDF-hTERT and primary
untransduced HDF although consistent with previous reports, cyclin D1 levels were
downregulated less efficiently following serum-starvation in TERT-expressing cells
compared with untransduced HDF.52 Qualitatively similar results were also obtained when
comparing multiple genetically unrelated hTERT-transduced HDF lines.
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To synchronize cells in quiescence, 10-cm dishes of HDFs were grown to confluence in
DMEM containing 10% FBS. Confluent cultures of HDF were placed in medium containing
0.1% serum for 16–24 hrs. The following day, cells were trypsinized and replated at 40–
50% confluence and maintained in 0.1% FBS for an additional 24 hours prior to adenoviral
transduction or siRNA transfection. Cells were maintained in 0.1% FBS throughout the
course of siRNA transfections or viral transductions. To stimulate cell cycle re-entry, cells
were treated with fresh medium containing 10% FBS. At various times after cell cycle entry
cells were harvested for analysis of protein markers (using immuno-blotting and kinase
assays), RNA (using microarray), or cell cycle parameters (using flow cytometry or [3H]-
thymidine incorporation).
siRNA transfections
For licensing factor depletion experiments quiescent HDF were transfected with siRNA
duplexes (Dharmacon Research) twice on consecutive days according to standard protocols
(Dharmacon Research). Target sequences of oligonucleotides used were as follows: Mcm7,
5'-AUC GGA UUG UGA AGA UGA A-3'; Control (Non-Targeting), 5'-UAG CGA CUA
AAC ACA UCA A-3'; Cdc6, 5'-ACA AUU AAG UCU CCU AGC A-3'; p27, 5'-GCA ACC
GAC GAU UCU UCU A-3'. The Mcm2 siRNA was a ‘SMARTPOOL’. In some
experiments, quiescent siRNA-transfected cells were also infected with adenoviruses (1 ×
1010/ml) for an additional 24 hrs, prior to serum stimulation.
mRNA extraction and analysis
Synchronized HDF were lysed with TRIzol reagent (Invitrogen) and total RNA was purified
according to the manufacturer's protocol. The concentration and purity of the RNA were
determined by measurements of absorbance at 260 and 280 nm. One microgram of RNA
was used for each RT-PCR reaction. RT-PCR was performed using the ThermoScript RT-
PCR system (Invitrogen) according to the manufacturer's instructions. 2 μl of the resulting
reaction products were used as templates in PCR reactions to amplify fragments of the
human Cyclin D1 and GAPDH cDNAs. Sequences of the oligonucleotide primer pair used
to amplify Cyclin D1 (750 bp) are: upstream primer 5' TGT TTG CAA GCA GGA CTT TG
3'; downstream primer 5' ACG TCA GCC TCC ACA CTC TT 3'. The sequences of
upstream and downstream primer used to amplify GAPDH are: 5' GAA GGT GAA GGT
CGG AGT 3' and GAA GAT GGT GAT GGG ATT TC 3'. The amplified PCR products
were separated on 1% agarose gels and visualized under an UV transilluminator.
Chromatin immunoprecipitation (ChIP) analysis of RNA polymerase II
Quiescent HDF were transfected with siRNA oligonucleotides as described above. After
stimulation with serum for various times, formaldehyde was added directly into culture
media to a final concentration of 1%, and the plates were rocked gently for 10 minutes to
generate cross-linked protein-DNA complexes. The cross-linking reaction was quenched by
adding glycine to a final concentration of 125 mM. After 10 minutes, the glycine-containing
medium was aspirated, and the cells were washed twice with ice-cold PBS containing
protease inhibitors and 1 mM phenylmethylsulfonyl fluoride. The cells were scraped into a
conical tube and collected by brief centrifugation. The resulting cell pellets were
resuspended in 1 ml of 0.1 M Tris-HCl (pH 9.4) and 0.1 M dithiothreitol, placed on ice for 5
min, and incubated at 30°C for 15 min. The cells were then collected by centrifugation and
washed sequentially with 1 ml of ice-cold PBS; 1 ml of 10 mM HEPES (pH 6.5), 0.25%
Triton X-100, 10 mM EDTA and 0.5 mM EGTA; and finally 1 ml of 10 mM HEPES (pH
6.5), 1 mM EDTA, 0.5 mM EGTA and 200 mM NaCl. The resulting cells were resuspended
in 0.35 ml of buffer containing 50 mM Tris-HCl (pH 8.0), 1% SDS and 10 mM EDTA
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supplemented with 1x protease inhibitor mixture (Roche) and incubated on ice for 15 min.
The resulting lysates were sonicated on ice to shear the DNA into 1–2-kb fragments.
Sonicated lysates were centrifuged for 10 min at 10,000 xg. The clarified supernatants
containing chromatin fragments were transferred to new tubes and normalized for protein
content. 5% of each sheared chromatin sample was saved to provide an “input” control. The
remainder of each chromatin solution was diluted to 1 ml with 20 mM Tris-Cl (pH 8.0), 1%
Triton X-100, 2 mM EDTA and 150 mM NaCl freshly supplemented with protease inhibitor
mixture. Each sample was supplemented with 400 μg/ml salmon sperm DNA and 1% bovine
serum albumin. Samples were then pre-cleared with 40 μl of a 50% protein A-agarose slurry
for 2 h at 4°C. Pre-cleared samples were immunoprecipitated with 2 μg of rabbit anti-
RNAPII antibody (Santa Cruz). After overnight incubation at 4°C, 40 μl of pre-blocked
protein G-agarose beads was added to each sample. 3 hr later, immune complexes were
collected by centrifugation. Beads were washed sequentially with 1 ml of buffer containing
20 mM Tris-Cl (pH 8.0), 0.1% SDS, 1% Triton X-100, 2 mM EDTA and 150 mM NaCl; 1
ml of buffer containing 20 mM Tris-Cl (pH 8.0), 0.1% SDS, 1% Triton X-100, 2 mM EDTA
and 500 mM NaCl; 1 ml of buffer containing 10 mM Tris-Cl (pH 8.0), 0.25 M LiCl, 1%
Nonidet P-40, 1% deoxycholate and 1 mM EDTA; and finally 1 ml of Tris/EDTA buffer.
Chromatin was eluted from the beads using 250 μl of 1% SDS in 0.1 M NaHCO3. Reverse
cross-linking was performed by overnight incubation at 45°C. After proteinase K (10 μg/ml)
and RNaseA (10 μg/ml) digestion, phenol/ chloroform extraction and ethanol precipitation,
immunoprecipitated DNA was re-suspended in 50 μl of distilled water and analyzed by
PCR. The PCR primers for the human Cyclin D1 promoter region are: upstream primer 5'
CCT TGG GCA TTT GCA ACG AC 3'; downstream primer 5' CGC ATT TCC AAG AAC
GCC AC 3'. The amplified DNA products were separated on 1% agarose gels and visualized
under a UV transilluminator.
RNA extraction and microarray analysis
Quiescent HDF were transfected sequentially with siCon and siMcm7 oligonucleotides. 48
hrs after transfection, cells were stimulated with 10% FBS for 4 hrs (or were left
unstimulated for controls). The resulting cells were lysed with TRIzol reagent (Invitrogen)
and total RNA was harvested according to the manufacturer's instructions. The resulting
RNA samples were submitted for microarray analysis by the Boston University Microarray
Core Facility
(http://www.bumc.bu.edu/busm-pathology/pathology-core-services/boston-university-
microarray-resource/) using the Affymetrix 1.0 ST Human Transcriptome array.
Flow cytometry
For BrdU labeling assays, cells were pulsed for one hour with 10 μM BrdU to label the S-
phase population. Cells were trypsinized, recovered by centrifugation for 30 s at 10,000 g
and fixed in PBS containing 35% ethanol for at least 1 hr at 4°C. Fixed cells were incubated
in 2N HCl for 20 minutes at room temperature. The HCl-treated cells were neutralized by
washing in 0.1 M borax (pH 8.5) then washed in PBS. The resulting cell pellets were
resuspended in 50 μl of antibody labeling solution comprising 30 μl PBS containing 0.5%
Tween-20 and 0.5% BSA plus 20 μl FITC-conjugated BrdU antibody (BD Biosciences).
The cells were incubated for 30 minutes in the dark with frequent mixing. Labeled cells
were re-suspended and washed in 1 ml PBS to remove free antibody. Washed nuclei were
re-suspended in 1 ml PBS containing 8 μg RNAse A and 50 μg Propidium Iodide. The
nuclear suspensions were incubated in the dark at room temperature for 30 min prior to
FACS analysis. Flow cytometry was performed on a Becton Dickinson instrument, exciting
at 488 nm and measuring the BrdU-linked green fluorescence (FITC) through a 514 nm
bandpass filter and the DNA-associated red fluorescence (PI) through a 600 nm wave-length
filter. Analysis was performed on Cellquest software. In some experiments, the BrdU-
Liu et al. Page 11













labeling was omitted and the ethanol-fixed cells were resuspended directly in 1 ml PBS
containing 8 μg RNAse A and 50 μg Propidium Iodide.
SDS PAGE and western blotting
Total cell lysates were prepared in lysis buffer containing 50 mM HEPES, pH 7.4, 0.1%
Triton X-100, 150 mM NaCl, 1 mM EDTA, 50 mM NaF, 80 mM β-glycerophosphate and
1x protease inhibitor mixture (Roche Applied Science). In some experiments, cells were
fractionated to generate soluble and chromatin-enriched nuclear fractions, exactly as
described previously by Liu et al.53 In brief, monolayers of cells were washed three times in
ice-cold phosphate-buffered saline (PBS) and scraped into 500 μl of ice-cold cytoskeleton
buffer (CSK buffer: 10 mM PIPES, pH 6.8, 100 mM NaCl, 300 mM sucrose, 3 mM MgCl2,
1 mM EGTA, 1 mM DTT, 0.1 mM ATP, 1 mM Na3VO4, 10 mM NaF and 0.1% Tritron
X-100) freshly supplemented with protease inhibitor cocktail. CSK lysates were transferred
to microcentrifuge tubes and incubated on ice for 5 minutes. The cell lysates were
centrifuged at 1,000 g for 2 minutes. The supernatants were removed and further clarified by
centrifugation at 10,000 g for 10 minutes to obtain Triton X-100-soluble fractions. The
Triton-extracted insoluble nuclear fractions were washed once with 1 ml of CSK buffer and
then re-suspended in a minimal volume of CSK. In some experiments as indicated,
chromatin-bound proteins were released by digestion of nuclei in CSK with 1000 U/ml of
RNAse-free DNAse I (Roche) at 25°C for 30 minutes. After digestion, soluble and insoluble
materials were separated by centrifugation at 10,000 g for 10 minutes. Total cell extracts and
soluble or nuclear protein samples were separated by SDS-PAGE, transferred to
nitrocellulose using Amersham Pharmacia Multiphor II NovaBlot semi-dry transfer
apparatus, and analyzed by immunoblotting with indicated antibodies. Anti-Cdc6 (sc-9964),
anti-Cdk2 (sc-163), anti-Cdk4 (sc-260), anti-Chk1 (sc-7898), anti-Chk2 (sc-9064), anti-
Cyclin D1 (sc-753), anti-Cyclin E (sc-247), anti-Cyclin A (sc-596), anti-Mcm2 (sc-10771),
anti-Mcm7 (sc-9966), anti-phospho S780-Rb (sc-12901), anti-Rb (sc-050), anti-p53
(sc-6243) were from Santa Cruz Biotechnology. Anti-β-actin antibody (A-5441) was
purchased from Sigma-Aldrich. Anti-p27 was from BD Biosciences.
In vitro kinase assays
To measure CDK4 and CDK2 kinase activity, cells were lysed for 30 min at 4°C in 0.5 ml
of buffer containing 50 mM HEPES (pH 7.5), 10 mM MgCl2, 150 mM NaCl, 0.1%
Tween-20, 1 mM dithiothreitol and 1x protease inhibitor cocktail. Cell lysates were then
sonicated twice on ice, 5 seconds each pulse, at 30% power. Lysates were cleared by
centrifugation at 10,000 xg for 10 minutes at 4°C. Supernatants were assayed for protein
concentration. Protein extracts (approximately 500 μg per sample), were precleared for 1
hour with 20 μl of a protein A/G agarose bead suspension (Santa Cruz) and 0.5 μg normal
rabbit IgG (Santa Cruz). Precleared lysates were then immunoprecipitated with 1 μg of
either CDK2 or CDK4 antibody (Santa Cruz). Antibody-antigen complexes were allowed to
form overnight at 4°C, with rotation. After extensive washing, immunoprecipitates were
resuspended in kinase buffer (50 mM HEPES [pH 8.0], 10 mM MgCl2, 2.5 mM EGTA, 1
mM dithiothreitol) supplemented with 25 μM unlabeled ATP, 2.5 μg of either glutathione S-
transferase-Rb protein (for CDK4, Santa Cruz) or histone H1 (for CDK2, Sigma) as
substrate and 10 μCi [γ-32P]ATP (6000 Ci/mmol, Perkin Elmer) per sample. Reactions were
incubated for 30 min at 30°C, and then terminated by the addition of 2x-Laemmli buffer.
Labeled proteins were resolved on an SDS 12.5% polyacrylamide gel, Coomassie stained,
dried onto Whatmann-filter paper, detected and quantified using a Bio-Rad Molecular
Imager FX phosphoimager.
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All data shown are from experiments that were performed at least three times with similar
results on each occasion.
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Abbreviations
ATM ataxia telangiectasia-mutated
ATR ATM- and Rad3-related
Cdc6 cell division cycle 6
CDK2 cyclin dependent kinase 2
CDK4 cyclin dependent kinase 4
ChIP chromatin immunoprecipitation
Chk1 checkpoint kinase 1
Chk2 checkpoint kinase 2
HDF human dermal fibroblasts
HPV human papilloma virus
IC initiation complex
Mcm mini-chromosome maintenance
ORC origin recognition complex
pre-RC pre-replicative complex
Rb retinoblastoma
RNA Pol II RNA polymerase II
siRNA small interfering RNA
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Acute depletion of Mcm7 inhibits S-phase entry in primary HDF. Quiescent hTERT-
expressing HDF were transfected with siMcm7 or siCon oligonucleotides, then stimulated to
enter the cell cycle. 24 hours after serum-stimulation, chromatin and soluble fractions were
prepared and analyzed by SDS-PAGE and immunoblotting for expression of various
proteins as indicated (A). Parallel cultures of siCon and siMcm7-transfected cells were
incubated with 25 μM BrdU for 1 hr. The cell cycle distributions of the resulting HDF were
analyzed by flow cytometry, as described under ‘Materials and Methods’ (B). In a similar
experiment, quiescent HDF were transfected with siMcm7 or siCon oligonucleotides, then
stimulated to enter the cell cycle. After 0, 12 and 15 hours of serum stimulation, cells were
lysed and CDK4 and CDK2 complexes were immunoprecipitated for in vitro kinase assays.
Rb-GST and histone H1 were used as substrates for CDK4 and CDK2 respectively (C).
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Mcm7 depletion inhibits cyclin D1 expression independently of p27. (A) Quiescent hTERT-
expressing HDF were transfected with siMcm7 or siCon oligonucleotides, then stimulated to
enter the cell cycle. After 0 hr, 4 hr, 12 hr and 16 hr of serum stimulation chromatin and
soluble fractions were prepared and analyzed for expression of various proteins (as
indicated) using SDS-PAGE and immunoblotting. (B) Quiescent hTERT-expressing HDF
were transfected with siMcm7 or siCon oligonucleotides, then stimulated to enter the cell
cycle. After 4 hr, total RNA was extracted from the cells and analyzed for cyclin D1 and
GPDH mRNAs using RT-PCR as described under ‘Materials and Methods’. (C) For ChIP
analyses, control and Mcm7-depleted cells were synchronized as described in (A). At
various times after stimulating cell cycle entry, chromatin fractions were harvested and
immunoprecipitated using α-RNA Pol II antibody. Total chromatin (‘Input’) and α-RNA-Pol
II immune complexes were analyzed by PCR using primers designed to amplify a fragment
of the CYCD1 promoter. (D) Quiescent hTERT-expressing HDF were transfected with
siCon, siMcm7 and sip27 individually or in combination. Transfected cells were stimulated
with serum and after 0 hr, 4 hr and 14 hr soluble fractions were prepared and analyzed by
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SDS-PAGE and immunoblotting for expression of various proteins as indicated. (E)
Quiescent hTERT-expressing HDF were transfected with siCon or siMcm7 for 24 hr.
Transfected cells were then infected with AdGFP or AdRaf1 + AdERK as indicated. Cells
were stimulated with serum and 4 hr after release from quiescence soluble fractions were
prepared and analyzed by SDS-PAGE and immunoblotting as indicated.
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Acute Mcm7 depletion does not trigger a checkpoint response. Quiescent hTERT-expressing
HDF were transfected with siMcm7 or siCon oligonucleotides and then stimulated to enter
the cell cycle. Some cultures of siCon-transfected cells were treated with 600 nM BPDE to
induce DNA damage. 12 hours after serum stimulation cells were lysed and analyzed by
SDS-PAGE and immunoblot using the indicated antibodies.
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Cdc6 is required for efficient cyclin D expression and G1-progression. (A) Quiescent
hTERT-expressing HDF were transfected with siCdc6 or siCon oligonucleotides, then
stimulated with serum. After 0 hr, 4 hr, 14 hr and 16 hr of serum stimulation soluble
fractions were prepared and analyzed for expression of various proteins using SDS-PAGE
and immunoblotting (upper). In a parallel experiment, siCdc6- or siCon-transfected cells
were stimulated with serum for 20 hr, then analyzed by flow cytometry (lower). (B)
Quiescent HDF were infected with adenovirus encoding HA-tagged Cdc6-A4 or with an
empty-vector control adenovirus (AdCon). 24 hours after infection, cells were stimulated
with serum. At different times after serum stimulation cells were harvested for PI staining
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and FACS analysis to determine cell cycle distributions. (C) Quiescent HDF were infected
with Ad HA-Cdc6-A4 or AdCon. 24 hours after infection, cells were stimulated with serum.
After 0 hr, 4 hr, 12 hr and 16 hr of serum stimulation soluble proteins were extracted and
analyzed by SDS-PAGE and immunoblotting for expression of various proteins as indicated.
(D) Quiescent HDF were infected with Ad HA-Cdc6-A4 or with an empty-vector control
adenovirus (AdCon). 24 hours after infection, cells were stimulated with serum for 4 hr.
Lysates from the resulting cells were immunoprecipitated with anti-cyclin D1 antibodies.
Immune complexes were assayed for Rb-directed kinase activity in vitro.
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HPV E7 expression allows S-phase entry of Mcm7-depleted cells. (A) Quiescent HDF were
transfected with siCon or siMcm7 for 24 hr. Transfected cells were then infected with
AdCon or AdCyclin D1 as indicated. Cells were stimulated with serum for 0 hr, 4 hr and 12
hr. Extracts from the resulting cells were analyzed by SDS-PAGE and immunoblotting with
various antibodies as indicated. (B) Quiescent HDF were transfected with siCon or siMcm7,
then infected with AdCon or AdE7 as described above. The resulting cells were incubated
with 10 μM BrdU for 1 hr, then analyzed by flow cytometry to determine cell cycle
distributions. (C) Quiescent HDF were transfected with siCon or siMcm7 for 24 hr.
Transfected cells were then infected with AdCon or AdE7 as indicated. After 20 hr of serum
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stimulation cell extracts were prepared and analyzed by SDS-PAGE and immunoblotting
with various as indicated.
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Replication licensing promotes G1 progression of untransformed human cells. In
untransformed human cells pre-RC assembly contributes to activation of G1 CDKs via
independent mechanisms involving Cyclin D1 induction and downregulation of p27. See
‘Discussion’ for details.
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